These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38043532)
21. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543 [TBL] [Abstract][Full Text] [Related]
22. A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses. Schmidt C; Hastert FD; Gerbeth J; Beissert T; Sahin U; Perkovic M; Schnierle BS Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146452 [TBL] [Abstract][Full Text] [Related]
23. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446 [TBL] [Abstract][Full Text] [Related]
24. Replicative Senescence-Associated LINE1 Methylation and LINE1-Alu Expression Levels in Human Endothelial Cells. Ramini D; Latini S; Giuliani A; Matacchione G; Sabbatinelli J; Mensà E; Bacalini MG; Garagnani P; Rippo MR; Bronte G; Bonafè M; Cardelli M; Olivieri F Cells; 2022 Nov; 11(23):. PubMed ID: 36497059 [TBL] [Abstract][Full Text] [Related]
25. NATURE OF THE LABILE IMMUNOGENIC SUBSTANCE IN THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. YOUMANS AS; YOUMANS GP J Bacteriol; 1964 Oct; 88(4):1030-7. PubMed ID: 14219015 [TBL] [Abstract][Full Text] [Related]
26. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Gutiérrez-Álvarez J; Honrubia JM; Sanz-Bravo A; González-Miranda E; Fernández-Delgado R; Rejas MT; Zúñiga S; Sola I; Enjuanes L Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34686605 [TBL] [Abstract][Full Text] [Related]
27. Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness. She L; Alanazi HH; Yan L; Brooks EG; Dube PH; Xiang Y; Zhang F; Sun Y; Liu Y; Zhang X; Li XD PLoS One; 2020; 15(7):e0236744. PubMed ID: 32730309 [TBL] [Abstract][Full Text] [Related]
28. Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress. Huang Z; Wang Y; Yao D; Wu J; Hu Y; Yuan A Nat Commun; 2021 Jan; 12(1):145. PubMed ID: 33420008 [TBL] [Abstract][Full Text] [Related]
29. Analysis of parvovirus infections using strand-specific hybridization probes. Bloom ME; Alexandersen S; Mori S; Wolfinbarger JB Virus Res; 1989 Sep; 14(1):1-25. PubMed ID: 2554612 [TBL] [Abstract][Full Text] [Related]
30. Cis- and trans-acting elements in cowpea mosaic virus RNA replication. Van Bokhoven H; Le Gall O; Kasteel D; Verver J; Wellink J; Van Kammen AB Virology; 1993 Aug; 195(2):377-86. PubMed ID: 8337819 [TBL] [Abstract][Full Text] [Related]
31. A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague. Shattock RJ; Andrianaivoarimanana V; McKay PF; Randriantseheno LN; Murugaiah V; Samnuan K; Rogers P; Tregoning JS; Rajerison M; Moore KM; Laws TR; Williamson ED Front Microbiol; 2023; 14():1247041. PubMed ID: 38029221 [TBL] [Abstract][Full Text] [Related]
32. Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action. Maruggi G; Ulmer JB; Rappuoli R; Yu D Curr Top Microbiol Immunol; 2022; 440():31-70. PubMed ID: 33861374 [TBL] [Abstract][Full Text] [Related]
33. A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Brito LA; Chan M; Shaw CA; Hekele A; Carsillo T; Schaefer M; Archer J; Seubert A; Otten GR; Beard CW; Dey AK; Lilja A; Valiante NM; Mason PW; Mandl CW; Barnett SW; Dormitzer PR; Ulmer JB; Singh M; O'Hagan DT; Geall AJ Mol Ther; 2014 Dec; 22(12):2118-2129. PubMed ID: 25027661 [TBL] [Abstract][Full Text] [Related]
34. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity. McCafferty S; Haque AKMA; Vandierendonck A; Weidensee B; Plovyt M; Stuchlíková M; François N; Valembois S; Heyndrickx L; Michiels J; Ariën KK; Vandekerckhove L; Abdelnabi R; Foo CS; Neyts J; Sahu I; Sanders NN Mol Ther; 2022 Sep; 30(9):2968-2983. PubMed ID: 35450821 [TBL] [Abstract][Full Text] [Related]
35. Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens. Penaloza-MacMaster P; Teigler JE; Obeng RC; Kang ZH; Provine NM; Parenteau L; Blackmore S; Ra J; Borducchi EN; Barouch DH J Virol; 2014 Jun; 88(11):6243-54. PubMed ID: 24648461 [TBL] [Abstract][Full Text] [Related]
36. Small-RNA-Mediated Genome-wide trans-Recognition Network in Tetrahymena DNA Elimination. Noto T; Kataoka K; Suhren JH; Hayashi A; Woolcock KJ; Gorovsky MA; Mochizuki K Mol Cell; 2015 Jul; 59(2):229-42. PubMed ID: 26095658 [TBL] [Abstract][Full Text] [Related]
37. IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. YOUMANS AS; YOUMANS GP J Bacteriol; 1965 May; 89(5):1291-8. PubMed ID: 14293000 [TBL] [Abstract][Full Text] [Related]
38. In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. Chang M; Marquardt AP; Wood BL; Williams O; Cotler SJ; Taylor SL; Carithers RL; Gretch DR J Virol; 2000 Jan; 74(2):944-55. PubMed ID: 10623757 [TBL] [Abstract][Full Text] [Related]
39. Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains. Hoffmann D; Schwarck D; Banning C; Brenner M; Mariyanna L; Krepstakies M; Schindler M; Millar DP; Hauber J PLoS One; 2012; 7(6):e38305. PubMed ID: 22675540 [TBL] [Abstract][Full Text] [Related]
40. Delayed hypersensitivity to fungal antigens in mice. II. Characterization of the active component in immunogenic RNA extracts. Rifkind D; Frey JA; Petersen EA; Dinowitz M J Infect Dis; 1976 May; 133(5):533-7. PubMed ID: 772131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]